Core Viewpoint - Nestlé has initiated a voluntary recall of certain batches of infant formula in multiple European countries due to quality issues identified in a supplier's raw material, which may contain cereulide toxin, a substance that can cause gastrointestinal problems [2][3]. Group 1: Recall Announcement - On January 5, Nestlé announced the recall in the UK, Germany, France, and Ireland, citing quality issues with a supplier's raw material [2]. - The following day, Nestlé China announced a voluntary recall of specific batches of infant formula sold in mainland China as a precautionary measure [2]. - Nestlé China confirmed that only a small number of products might be affected and emphasized that all other registered products in the mainland market remain safe for consumption [2][3]. Group 2: Product Details - The recall in Europe involves different brand names across countries, such as BEBA and ALFAMINO in Germany, and SMA in the UK [3]. - In China, the recall includes 30 batches of products under the brands of力多精, 能恩, and 惠氏, all with expiration dates extending to 2027 [3]. - Nestlé has stated that no illnesses or symptoms related to the consumption of the affected products have been confirmed to date [3].

1月7日，雀巢中国相关负责人向南都.湾财社记者表示，雀巢中国高度重视此事，中国市场少数产品可能受到影响，作为预防性举措，雀巢中国已经对部 分特定批次的婴幼儿配方奶粉进行了回收。截至目前，尚未收到与相关产品有关的任何不适报告，所有在中国大陆市场注册并销售的雀巢特殊医学用途婴 儿配方食品、超启能恩、启赋、S26铂臻等不受影响。 南都.湾财社记者注意到，次日(1月6日)，雀巢中国官网亦发布公告称，作为一项预防性措施，自愿回收在中国大陆销售的特定批次婴幼儿配方奶粉。 公告显示，雀巢的调查显示，这些原料中可能含有蜡样芽孢杆菌毒素(cereulide)，这是一种源自蜡样芽孢杆菌的细菌性物质，可能导致腹泻、呕吐等消化 问题。经供应商确认，该物质来源于一种富含花生四烯酸(ARA)的油脂，而这种油脂被用于某些婴儿配方奶粉中。 1月5日，瑞士食品巨头雀巢(Nestlé)宣布，在英国、德国、法国、爱尔兰等多个欧洲国家召回部分批次奶粉，雀巢指出，在调查中发现其供应商生产的某 种原料存在质量问题。 南都.湾财社记者注意到，雀巢已于1月5日在前述多个欧洲国家的公司官网发布了该自愿性预防性召回公告。 所有在中国大陆市场注册并销售的雀巢特殊 ...

Core Viewpoint - Nestlé has initiated a voluntary recall of certain batches of infant formula in 31 countries due to the detection of trace amounts of Cereulide, a toxin produced by Bacillus cereus, in ARA oil supplied by vendors [1][3]. Group 1: Recall Details - The recall affects 30 batches of four major brands in mainland China and 41 batches of imported products through cross-border e-commerce [1][3]. - The affected batches represent less than 0.5% of Nestlé's annual sales, estimated at approximately 4.57 million Swiss francs (around 400 million RMB) [3][4]. Group 2: Company Response - Nestlé China has emphasized that it has not received any reports of adverse effects related to the recalled products and that other infant formula products in the Chinese market remain unaffected [3]. - The company views the recall as a responsible action to prevent potential consumer harm, aligning with industry standards for proactive measures [5][6]. Group 3: Industry Context - ARA oil is a common ingredient in infant formula, with a limited number of suppliers controlling 90% of global production, indicating that issues with any single supplier can escalate into a broader industry crisis [7]. - The toxin Cereulide is heat-resistant and can cause acute nausea, vomiting, and diarrhea, highlighting the importance of stringent safety measures in food production [11]. Group 4: Supplier Information - One of Nestlé's ARA suppliers, "Jiabiyou," is currently conducting tests on the affected raw materials, with results pending [8][9]. - Jiabiyou reported a revenue of 428 million RMB for the first three quarters of 2025, reflecting a year-on-year growth of 10.54% [9]. Group 5: Regulatory Insights - The presence of Bacillus cereus and its toxins is not typically included in mandatory testing lists in many countries, suggesting a gap in current food safety regulations [12][13]. - Experts recommend that companies adopt proactive monitoring and risk assessment mechanisms for non-mandatory pathogens to enhance food safety [13].

Core Viewpoint - Nestlé has initiated a precautionary recall of infant formula in several European countries due to quality issues with a supplier's ingredient, raising concerns about product safety and quality standards in the global food industry [1][4][5]. Group 1: Recall Announcement - On January 5, 2026, Nestlé announced a recall of a batch of infant formula in Germany, Austria, Denmark, Italy, and Sweden due to a "quality issue" with a specific ingredient [1]. - The company stated that it has conducted tests on potentially affected products and has not received any reports of illness related to the consumption of the recalled formula [1]. - Nestlé China confirmed that some products in the Chinese market may be affected and has also initiated a recall of specific batches as a precautionary measure [4]. Group 2: Market Position and Brand Strategy - Nestlé is a significant player in the global infant formula market, controlling a substantial market share in various regions, including 20% in Africa through brands like Cerelac and Nido [7]. - The company has adapted its product formulations in response to new national standards, such as increasing the types or amounts of certain beneficial oils in its products [6]. - Nestlé sells different brands in various countries, indicating a tailored approach to meet local market demands [6]. Group 3: Quality Concerns and Historical Context - Nestlé has faced multiple quality issues in recent years, including recalls due to high mineral content and potential contamination with Cronobacter [10][11]. - A report by a Swiss NGO highlighted discrepancies in sugar content in infant products sold in poorer countries compared to those in Europe, raising ethical concerns about product formulations [7]. - The company has been criticized for adding non-essential nutrients to attract children, which may lead to dependency on their products [9]. Group 4: Financial Performance and Market Challenges - Nestlé's infant nutrition business has shown fluctuations in performance, with sales in China experiencing a decline due to increased competition from local brands and changing market dynamics [13][14]. - In 2022, Nestlé reported a total revenue of 94.4 billion Swiss francs, with a slight growth in its infant nutrition segment, but faced challenges in maintaining market share [13]. - By 2025, the company reported a decline in total sales in the Greater China region, highlighting the pressures from local competitors and a decreasing birth rate [14][15].

据新华社消息，总部位于瑞士的雀巢公司1月6日表示，已在全球31个国家和地区发布针对部分批次婴幼 儿配方奶粉产品的召回通知。 同日，雀巢中国网站发布2条"预防性自愿回收婴幼儿配方奶粉"公告，拟对"Nestlé BEBA Supreme""惠氏 Wyeth启赋未来"等41个涉事批次进口自欧洲、在中国大陆跨境电商渠道销售的婴幼儿配方奶粉进行预 防性召回，同时回收30批次在中国大陆销售的特定批次婴幼儿配方奶粉（包含1款儿童奶粉），合计召 回71批次。截至目前，雀巢尚未收到与相关产品有关的任何不适报告。 雀巢启动全球奶粉召回 根据雀巢全球官网消息，其已在全球31个国家和地区发布针对部分批次婴幼儿配方奶粉产品的召回通 知。 该公司对用于生产可能受影响的婴幼儿配方奶粉产品的所有花生四烯酸油（ARA）及相关油脂混合物 进行检测发现，供应商提供的这种油脂原料存在质量问题，相关批次婴幼儿配方奶粉中可能存在蜡样芽 孢杆菌（Cereulide），这种细菌可能引起食源性疾病。 雀巢表示，由于花生四烯酸油被广泛用于多种婴幼儿配方奶粉，此次召回涉及多个国家和地区、品牌和 产品，但目前尚未确认有任何消费者因食用相关产品而出现患病情况。 针对 ...

另据雀巢官网近期发布的婴配粉产品咨询问答录，公司正与相关国家的相关部门保持联系，确保采取必 要措施。雀巢向家长和照顾者保证，正在采取适当措施，帮助确保家庭及其婴儿的健康与福祉。同时， 公司也在努力尽量减少潜在的供应中断。 其进一步介绍，Cereulide会引起食源性疾病，由某些菌株--蜡样芽孢杆菌(Bacilus cereus)产生。油品中 存在相关物质非常罕见，雀巢正与油品供应商合作，进行全面的原因分析。 刚刚迎来在华业务合并的惠氏营养品业务和雀巢婴儿营养品业务，于2026年开年遭遇内部冲击。由于供 应商提供的油脂原料存在质量问题，在全球多地销售的相关批次婴幼儿配方奶粉将召回，而中国大陆市 场亦位列其中。 近日，雀巢发布针对部分批次婴幼儿配方奶粉产品的召回通知。称公司对用于生产可能受影响的婴幼儿 配方奶粉产品的所有花生四烯酸油及相关油脂混合物进行了检测，发现供应商提供的这种油脂原料存在 质量问题，相关批次婴幼儿配方奶粉中可能存在蜡样芽孢杆菌，这种细菌可能引起食源性疾病。 根据雀巢中国官网公布的两份自愿回收婴幼儿配方奶粉公告。其中一份提到，所有在中国大陆市场注册 并销售的雀巢特殊医学用途婴儿配方食品、超启能恩 ...

Group 1 - Nestlé has initiated a recall of infant formula products across multiple countries due to quality issues with Arachidonic Acid (ARA) raw materials supplied by a vendor, which may contain Bacillus cereus, a bacteria that can cause foodborne illness [3][4] - The UK Food Standards Agency has warned that Bacillus cereus is highly heat-stable, making it difficult to eliminate through cooking or boiling, and can lead to symptoms such as nausea, vomiting, and abdominal cramps [3] - As a precautionary measure, Nestlé China has recalled specific batches of infant formula, although it has not received any reports of illness related to the affected products [4] Group 2 - Jia Bi You, the largest domestic supplier of ARA products, reported a revenue increase of 10.56% year-on-year to 428 million yuan and a net profit increase of 54.18% to 129 million yuan in the first three quarters [6] - The company is expanding its international customer base and enhancing its overseas sales capabilities, aiming to integrate its products into the supply chains of major multinational infant formula companies [6][7] - Jia Bi You has established long-term partnerships with well-known infant formula companies such as Nestlé, Danone, and Cargill, ensuring a stable foundation for its operations [7] Group 3 - ARA is an essential fatty acid for infant growth and development, crucial for brain and retinal development, and is widely used in infant formula [5] - The maximum allowable addition of ARA in infant formula is 19.1 mg/100 kJ, consistent with standards in the EU, Australia, and New Zealand [5] - As of January 7, Jia Bi You's stock price was 24.01 yuan per share, with a market capitalization of 4.041 billion yuan [8]

伯恩斯坦：将雀巢目标价从79瑞郎下调至74瑞郎。 ...

Core Viewpoint - Nestlé has initiated a voluntary recall of certain batches of infant formula in multiple European countries and China due to quality issues identified in a supplier's raw material, which may contain a bacterial toxin that can cause digestive problems [1][2]. Group 1: Recall Details - The recall affects specific batches of infant formula sold in the UK, Germany, France, and Ireland, with Nestlé confirming that the issue stems from a supplier's ingredient potentially containing cereulide toxin [1][2]. - In China, Nestlé announced the recall of 30 batches of products, including brands like 力多精, 能恩, and 惠氏, all with expiration dates extending to 2027 [2][5]. - The affected products in China include various stages of infant formula, with specific batch numbers listed for consumer reference [5][6]. Group 2: Safety Measures - Nestlé has stated that, despite the low levels of the detected toxin, the recall is a precautionary measure, and no illnesses related to the affected products have been reported to date [2][3]. - The company emphasizes that all other products and batches not included in the recall are safe for consumption, reinforcing their commitment to product quality and safety management [2][3].

每经记者｜范芊芊 每经编辑｜何小桃 魏文艺 日前，雀巢在欧洲多国召回数批次婴儿奶粉，涉及德国、奥地利、丹麦、瑞典及法国。据悉，此次召回的原因是调查发现从某大型供应商处采购的一种原 料存在质量问题，可能存在源自蜡样芽孢杆菌的细菌源性物质，导致消化系统不适（腹泻和呕吐）。 《每日经济新闻》记者注意到，1月6日，雀巢中国在其官网也发布了预防性自愿回收婴幼儿配方奶粉的公告。公告称，雀巢中国自愿回收在中国大陆销售 的特定批次婴幼儿配方奶粉，受影响产品涉及力多精、铂初能恩、舒宜能恩、惠氏多批次产品。另外，雀巢中国也自愿回收所有此次涉事的进口自欧洲、 在中国大陆跨境电商渠道销售的婴幼儿配方奶粉。 校对|段炼 封面图片来源：雀巢官网 图片来源：雀巢中国官网 雀巢中国强调称，本次回收范围之外的所有其他雀巢产品及同类产品的其他批次均可安全食用。所有在中国大陆市场注册并销售的雀巢特殊医学用途婴儿 配方食品、超启能恩、启赋、S26铂臻等不受影响，所有在中国大陆跨境电商销售的雀巢能恩全护6HMO、NAN Supreme、S26金装等不受影响。 1月7日，雀巢中国方面向《每日经济新闻》记者表示："雀巢中国对此高度重视，中国市场少数产品可 ...